Odyssey Therapeutics, Inc. (ODTX)
Nasdaq: ODTX · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2021
Who owns Odyssey Therapeutics, Inc.
As filed with the SECHolders of 5% or more
6
Fmr LLC holds 10.2% of COMMON STOCK, as its SCHEDULE 13G filed Jun 5, 2026 says.
Directors and officers
17
report now, of 17 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Fmr LLC
SCHEDULE 13G · filed Jun 5, 2026 · COMMON STOCK
SR One Capital Management, LLC
SCHEDULE 13D · filed May 18, 2026 · Common Stock, $0.0001 par value per share
Tpg Gp A, LLC
SCHEDULE 13D · filed May 18, 2026 · Common Stock, par value $0.0001 per share
Jeito II S.L.P.
SCHEDULE 13D · filed May 15, 2026 · COMMON STOCK, $0.0001 par value per share
Lightspeed Venture Partners XV-B (Ignite), L.P.
SCHEDULE 13G · filed May 18, 2026 · Common Stock, $0.0001 par value per share
Dimension Management, L.P.
SCHEDULE 13D · filed May 15, 2026 · Common Stock, $0.0001 par value per share
What ODTX reports owning in othersstakes of 5% or more, and other ties
Odyssey Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$40.3Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window7 of 22 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| George Simeon | 10% owner | 3 | $0 | 0 | 3 | $10.0M |
| Haas Jason | Chief Financial Officer | 0 | $0 | 0 | 1 | $0 |
| Dimension Capital II, L.P. | director | 0 | $0 | 0 | 1 | $20.0M |
| Chu Shelley | director | 0 | $0 | 0 | 1 | $200,000 |
| Leiden Jeffrey M | director | 0 | $0 | 0 | 1 | $100,000 |
| Li Nan (Ln) | director | 0 | $0 | 0 | 1 | $20.0M |
| Coulter James G | 10% owner | 0 | $0 | 0 | 1 | $25.0M |